Ma, Q.; Liu, Z.; Wang, T.; Zhao, P.; Liu, M.; Wang, Y.; Zhao, W.; Yuan, Y.; Li, S.
Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN. Int. J. Mol. Sci. 2023, 24, 16503.
https://doi.org/10.3390/ijms242216503
AMA Style
Ma Q, Liu Z, Wang T, Zhao P, Liu M, Wang Y, Zhao W, Yuan Y, Li S.
Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN. International Journal of Molecular Sciences. 2023; 24(22):16503.
https://doi.org/10.3390/ijms242216503
Chicago/Turabian Style
Ma, Qinsiyu, Zhan’ao Liu, Tengyu Wang, Pengfei Zhao, Mingrui Liu, Yifang Wang, Weitong Zhao, Ying Yuan, and Shuo Li.
2023. "Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN" International Journal of Molecular Sciences 24, no. 22: 16503.
https://doi.org/10.3390/ijms242216503
APA Style
Ma, Q., Liu, Z., Wang, T., Zhao, P., Liu, M., Wang, Y., Zhao, W., Yuan, Y., & Li, S.
(2023). Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN. International Journal of Molecular Sciences, 24(22), 16503.
https://doi.org/10.3390/ijms242216503